EODData

NASDAQ, TRVI: Trevi Therapeutics Inc

06 May 26 15:59
LAST:

14.28

CHANGE:
 0.40
OPEN:
14.14
HIGH:
14.44
ASK:
0.00
VOLUME:
1.13M
CHG(%):
2.73
PREV:
14.66
LOW:
13.65
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
06 May 2614.1414.4413.6514.261.73M
05 May 2614.4914.7814.2814.661.02M
04 May 2613.7814.6713.6914.382.38M
01 May 2613.8614.0613.7113.871.14M
30 Apr 2614.0314.1913.1113.762.86M
29 Apr 2613.6714.1613.5313.821.59M
28 Apr 2614.2414.5713.5113.841.16M
27 Apr 2614.4814.8914.1914.271.28M
24 Apr 2614.0014.4614.0014.41970.2K
23 Apr 2614.7814.8913.9514.191.79M

PROFILE

Name:Trevi Therapeutics Inc
About:Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase 2b Cough Reduction in IPF with nalbuphine ER clinical trial for treatment of chronic cough in patients with IPF; phase 2 clinical trial in patients with pruritus; and phase 2b/3 clinical trial in patients with prurigo nodularis. Trevi Therapeutics, Inc. has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in various formulations. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut.
Sector:Healthcare
Industry:Biotechnology
Address:195 Church Street, New Haven, CT, United States, 06510
Website:https://www.trevitherapeutics.com
CUSIP:89532M101
CIK:0001563880
ISIN:US89532M1018
FIGI:BBG003QGQRB9

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-22.77 
Forward P/E:-22.57 
PEG Ratio:0.91 
Price to Book:8.93 
Return on Assets:-0.23 
Return on Equity:-0.36 
EPS Ratio:-0.32 
Shares:128.4M 
Market Cap:1.834B 

TECHNICAL INDICATORS

MA5:14.190.7%
MA10:14.150.9%
MA20:14.210.5%
MA50:12.7312.1%
MA100:12.0718.3%
MA200:10.8032.3%
STO9:44.25
STO14:21.19
RSI14:46.96
WPR14:-69.51
MTM14:-0.97
ROC14:-0.06 
ATR:0.88 
Week High:14.783.5%
Week Low:13.118.9%
Month High:16.1212.9%
Month Low:11.6832.3%
Year High:16.1212.9%
Year Low:5.38165.4%